Trials / Unknown
UnknownNCT05011474
Safety and Efficacy Study of Matrilin-3 Pretreated Autologous Adipose Derived Mesenchymal Stem Cells Implantation in Chronic Low Back Pain Patients With Lumbar Intervertebral Disc Degeneration
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 4 (estimated)
- Sponsor
- Inbo Han · Academic / Other
- Sex
- All
- Age
- 19 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the safety and efficacy of autologous adipose-derived mesenchymal stem cell spheroids pretreated with matrillin-3 in chronic low back pain patients with lumbar intervertebral disc degeneration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | administered an autologous adipose-derived mesenchymal stem cell spheroid pretreated with matrillin 3 | Adipose-derived mesenchymal stem cells isolated from subject's adipose tissue are pretreated with matrillin 3 and produced in spheroid form. |
Timeline
- Start date
- 2021-04-23
- Primary completion
- 2022-01-20
- Completion
- 2022-12-31
- First posted
- 2021-08-18
- Last updated
- 2021-08-25
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05011474. Inclusion in this directory is not an endorsement.